Literature DB >> 15604048

A survey of characteristics of smokeless tobacco users in a treatment program.

Jon O Ebbert1, Martin D Klinkhammer, Susanna R Stevens, Leah C Rowland, Kenneth P Offord, Steven C Ames, Lowell C Dale.   

Abstract

OBJECTIVE: To determine the characteristics and outcomes of smokeless tobacco (ST) users receiving interventions in an outpatient tobacco-dependence treatment program.
METHODS: Survey was mailed with telephone follow-up to ST users treated during a 2-year period.
RESULTS: Nicotine replacement therapy and family and social support were the most helpful intervention components in maintaining tobacco abstinence. Continuing ST users face significant barriers to abstinence such as high levels of nicotine dependence, lack of motivation, nicotine withdrawal symptoms, and stress.
CONCLUSIONS: Enhancing confidence in their ability to quit, managing stress, prescribing bupropion SR, offering nicotine replacement therapy to relieve withdrawal symptoms, and providing ongoing support may be important for ST users in tobacco- dependence treatment programs.

Entities:  

Mesh:

Year:  2005        PMID: 15604048     DOI: 10.5993/ajhb.29.1.3

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  3 in total

Review 1.  Pharmacological interventions for the treatment of smokeless tobacco use.

Authors:  Jon O Ebbert; Karl Fagerstrom
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  Bupropion SR for the treatment of smokeless tobacco use.

Authors:  Lowell C Dale; Jon O Ebbert; Elbert D Glover; Ivana T Croghan; Darrell R Schroeder; Herbert H Severson; Richard D Hurt
Journal:  Drug Alcohol Depend       Date:  2007-03-13       Impact factor: 4.492

3.  The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).

Authors:  Jon O Ebbert; Christi A Patten; Darrell R Schroeder
Journal:  Addict Behav       Date:  2006-01-31       Impact factor: 3.913

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.